November 22, 1996



          Securities & Exchange Commission
          Judiciary Plaza
          450 Fifth Street, N.W.
          Washington, D.C.  20549

               Re:  Gerber Scientific, Inc.
                    Commission File No. 1-5865

          Gentlemen:

          Pursuant   to  regulations   of   the  Securities   and  Exchange
          Commission,  submitted herewith  for filing  on behalf  of Gerber
          Scientific,  Inc. (the "Company") is  the Company's Form 10-Q for
          the quarter ended October 31, 1996.

          This  filing  is being  effected  by direct  transmission  to the
          Commission's EDGAR System.


                                        Very truly yours,



                                        /s/ Gary K. Bennett
                                        Senior Vice President, Finance
<PAGE>1

                    UNITED STATES SECURITIES AND EXCHANGE COMMISSION

                                 WASHINGTON, D.C.  20549


                                        FORM 10-Q

            (MARK ONE) QUARTERLY REPORT / X /  OR TRANSITION REPORT /  /    
                           PURSUANT TO SECTION 13 OR 15(d) OF
                           THE SECURITIES EXCHANGE ACT OF 1934



        For the quarter end
         October 31, 1996                             Commission File No. 1-5865



                                GERBER SCIENTIFIC, INC.
                 -------------------------------------------------------        
                 (Exact name of Registrant as specified in its charter)




                  CONNECTICUT                                   06-0640743     
        -------------------------------                     -------------------
        (State or other jurisdiction of                       (I.R.S. Employer
        incorporation or organization)                      Identification No.)



          83 Gerber Road West, South Windsor, Connecticut             06074  
        --------------------------------------------------         ----------
              (Address of principal executive offices)             (Zip Code)



        Registrant's Telephone Number, including area code       (860) 644-1551 
                                                                 --------------

        Indicate by check mark whether the  registrant (1) has filed all reports
        required  to be filed by Section 13  or 15(d) of the Securities Exchange
        Act of 1934  during the preceding 12 months (or  for such shorter period
        that the  registrant was required to file such reports) and (2) has been
        subject to such filing requirements for the past 90 days.

                                Yes / X /  .   No /  / .
                                     

        At October 31, 1996, 23,231,600 shares of common stock of the Registrant
        were outstanding.
<PAGE>2

                                 GERBER SCIENTIFIC, INC.
                                    AND SUBSIDIARIES

                        CONTENTS OF QUARTERLY REPORT ON FORM 10-Q

                             Quarter ended October 31, 1996


                                                                        PAGE
                                                                        ----  

        Part I - Financial Information

           Item 1.  Consolidated Financial Statements:

                    Statement of Earnings for the three months            2
                    ended October 31, 1996 and 1995                        

                    Statement of Earnings for the six months              3
                    ended October 31, 1996 and 1995                        

                    Balance Sheet at October 31, 1996 and                 4
                    April 30, 1996                                         

                    Statement of Cash Flows for the six months            5
                    ended October 31, 1996 and 1995                        

                    Notes to Financial Statements                         6 

                    Independent Accountants' Report                       8 

           Item 2.  Management's Discussion and Analysis of               9
                    Financial Condition and Results of Operations          


        Part II - Other Information

           Item 4.  Submission of Matters to a Vote                      12
                    of Security Holders                                    

           Item 6.  Exhibits and Reports on Form 8-K                     12  


        Signature                                                        13


        Exhibit Index



                                          -1-
<PAGE>3

                        GERBER SCIENTIFIC, INC. AND SUBSIDIARIES

                           CONSOLIDATED STATEMENT OF EARNINGS

       ------------------------------------------------------------------------
                                                            In Thousands 
                                                     (except per share amounts) 
       ------------------------------------------------------------------------
       Three Months Ended October 31,                    1996            1995
       ------------------------------------------------------------------------

       Revenue:

          Product sales                               $  83,348       $  78,699
          Service                                        11,603          11,459
                                                      ---------       ---------
                                                         94,951          90,158
                                                      ---------       ---------
       Costs and Expenses:

          Cost of product sales                          45,017          41,727
          Cost of service                                 7,405           7,539
          Selling, general and administrative            30,380          27,950
          Research and development expenses               7,433           6,055
                                                      ---------       ---------
                                                         90,235          83,271
                                                      ---------       ---------

       Operating income                                   4,716           6,887

       Other income                                       2,302             939
       Interest expense                                     (83)            (93)
                                                      ---------       ---------

       Earnings before income taxes                       6,935           7,733

       Provision for income taxes                         1,800           2,200
                                                      ---------       ---------

       Net earnings                                   $   5,135       $   5,533
                                                      =========       =========

       Net earnings per common share                  $     .22       $     .23
                                                      =========       =========

       Dividends paid per common share                $     .08       $     .08
                                                      =========       =========
       Average common shares outstanding                 23,327          23,912
                                                      =========       =========


                                 See Accompanying Notes



                                          -2-
<PAGE>4

                        GERBER SCIENTIFIC, INC. AND SUBSIDIARIES

                           CONSOLIDATED STATEMENT OF EARNINGS
       ------------------------------------------------------------------------
                                                            In Thousands 
                                                     (except per share amounts)
       ------------------------------------------------------------------------
       Six Months Ended October 31,                      1996            1995
       ------------------------------------------------------------------------

       Revenue:

          Product sales                               $ 157,878       $ 155,772
          Service                                        22,881          22,577
                                                      ---------       ---------
                                                        180,759         178,349
                                                      ---------       ---------
       Costs and Expenses:

          Cost of product sales                          87,202          83,522
          Cost of service                                14,362          14,959
          Selling, general and administrative            58,975          55,726
          Research and development expenses              14,209          12,132
                                                      ---------       ---------
                                                        174,748         166,339
                                                      ---------       ---------

       Operating income                                   6,011          12,010

       Other income                                       3,300           2,313
       Interest expense                                    (173)           (197)
                                                      ---------       ---------

       Earnings before income taxes                       9,138          14,126

       Provision for income taxes                         2,400           4,100
                                                      ---------       ---------

       Net earnings                                   $   6,738       $  10,026
                                                      =========       =========

       Net earnings per common share                  $     .29       $     .42
                                                      =========       =========

       Dividends paid per common share                $     .16       $     .16
                                                      =========       =========
       Average common shares outstanding                 23,350          23,954
                                                      =========       =========

                                 See Accompanying Notes



                                          -3-
<PAGE>5

                         GERBER SCIENTIFIC, INC. AND SUBSIDIARIES

                                CONSOLIDATED BALANCE SHEET
                                                                               
                                                              In Thousands     
       ------------------------------------------------------------------------
                                                        October 31,   April 30,
                                                            1996          1996  
       ------------------------------------------------------------------------
                                          ASSETS

       Current Assets:
         Cash and short-term cash investments          $    7,282    $    8,704
         Accounts receivable                               83,786        74,035
         Inventories                                       63,481        63,196
         Prepaid expenses                                  13,372        12,021
                                                       ----------    ----------
                                                          167,921       157,956
                                                       ----------    ----------

       Investments and long-term 
         receivables                                       52,875        59,594
                                                       ----------    ----------

       Property, plant and equipment                      110,638       109,430
         Less accumulated depreciation                     54,510        54,692
                                                       ----------    ----------
                                                           56,128        54,738
                                                       ----------    ----------

       Intangible assets                                   49,050        48,576
         Less accumulated amortization                     10,073         9,327
                                                       ----------    ----------
                                                           38,977        39,249
                                                       ----------    ----------
       Other assets                                         1,252         1,451
                                                       ----------    ----------
                                                       $  317,153    $  312,988
                                                       ==========    ==========

                           LIABILITIES AND SHAREHOLDERS' EQUITY

       Current Liabilities:
         Notes payable                                 $       --    $       --
         Current maturities of long-term debt                 193           193
         Accounts payable                                  14,609        12,895
         Accrued compensation and benefits                 11,983        13,673
         Other accrued liabilities                         17,279        18,351
         Deferred revenue and litigation award              8,865         8,512
         Advances on sales contracts                        2,725         2,672
                                                       ----------    ----------
                                                           55,654        56,296
                                                       ----------    ----------

       Noncurrent Liabilities:
         Deferred income taxes                             11,219        10,056
         Long-term debt                                     7,242         7,338
                                                       ----------    ----------
                                                           18,461        17,394
                                                       ----------    ----------<PAGE>

       Contingencies and Commitments

       Shareholders' Equity:
         Preferred stock, no par value; authorized
           10,000,000 shares; no shares issued                 --            --
         Common stock, $1.00 par value; authorized
           65,000,000 shares; issued and outstanding 
           23,231,600 and 23,198,725 shares                23,232        23,199
         Paid-in capital                                   35,460        35,218
         Retained earnings                                182,332       179,307
         Cumulative translation component                   2,014         1,574 
                                                       ----------    ----------
                                                          243,038       239,298
                                                       ----------    ----------
                                                       $  317,153    $  312,988
                                                       ==========    ==========

                                  See Accompanying Notes


                                          -4-
<PAGE>6

                         GERBER SCIENTIFIC, INC. AND SUBSIDIARIES

                           CONSOLIDATED STATEMENT OF CASH FLOWS
                                                                            
                                                                In Thousands    
      --------------------------------------------------------------------------
       Six Months Ended October 31,                           1996         1995 


      --------------------------------------------------------------------------
       CASH PROVIDED BY (USED FOR):
       Operating Activities
         Net earnings                                     $  6,738     $ 10,026
         Adjustments to reconcile net earnings to
           cash provided by operating activities:
             Depreciation and amortization                   5,894        5,248
             Deferred income taxes                           1,163         (644)
             Changes in operating accounts, net of 
               effects from business acquisitions:
                 Receivables                               (10,933)      (5,040)
                 Inventories                                  (285)      (4,950)
                 Prepaid expenses                           (1,351)       3,034
                 Accounts payable and accrued expenses        (642)      (8,749)
                                                           --------    --------
       Provided by (Used for) Operating Activities             584       (1,075)
                                                           --------    --------

       Financing Activities
         Purchase of common stock                               --       (5,274)
         Repayments of long-term debt                          (96)         (96)
         Exercise of stock options                             275          559
         Dividends on common stock                          (3,713)      (3,802)
                                                          --------     --------

       (Used for) Financing Activities                      (3,534)      (8,613)
                                                          --------     --------
       Investing Activities
         Long-term debt securities                           7,268       15,258
         Business acquisitions                                  --         (486)
         Additions to property, plant and equipment         (6,440)      (7,461)
         Intangible and other assets                          (373)      (1,071)
         Other long-term investments                         1,073         (241)
                                                          --------     --------

       Provided by Investing Activities                      1,528        5,999
                                                          --------     --------
       (Decrease) in Cash and Short-Term
         Cash Investments                                   (1,422)      (3,689)

       Cash and Short-Term Cash Investments,
         Beginning of Period                                 8,704       10,208
                                                          --------     --------
       Cash and Short-Term Cash Investments, 
         End of Period                                    $  7,282     $  6,519
                                                          ========     ========

                                  See Accompanying Notes


                                          -5-
<PAGE>7

                        GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
                       NOTES TO CONSOLIDATED FINANCIAL STATEMENTS



          NOTE 1

          The   consolidated  balance   sheet  at   October  31,   1996,   the
          consolidated statements  of earnings  for the  three- and  six-month
          periods ended  October  31,  1996  and 1995,  and  the  consolidated
          statement of cash flows for the  six-month periods ended October 31,
          1996  and 1995  are unaudited  but, in  the opinion  of the Company,
          include  all  adjustments,  consisting  only   of  normal  recurring
          accruals, necessary  for a  fair statement  of the  results for  the
          interim  periods.   The  results  of  operations for  the  six-month
          period ended October 31, 1996 are  not necessarily indicative of the
          results to be expected for the full fiscal year.

          NOTE 2

          The classification of inventories was as follows (in thousands):

                                      October 31, 1996    April 30, 1996 
                                      ----------------    --------------
             Raw materials and
               purchased parts          $ 51,518             $ 51,493
             Work in process              11,963               11,703
                                        --------             --------
                                        $ 63,481             $ 63,196
                                        ========             ========

          NOTE 3

          Net  earnings per common share  were calculated on  the basis of the
          weighted average number of shares of  common stock and common  stock
          equivalents outstanding during each period.


          NOTE 4

          Included in this year's second quarter  and six months ended October
          31, 1996 was  a gain of $1,032,000  ($.04 per share) resulting  from
          life insurance benefits the Company received  upon the death of  Mr.
          H.  Joseph Gerber,  the  Company's former  Chairman  and  President.
          Life insurance benefits are tax-exempt, and  as a result, the income
          tax provision rates were comparatively lower  in the three- and six-
          month periods ended October 31, 1996.


                                             -6-
<PAGE>8

                        GERBER SCIENTIFIC, INC. AND SUBSIDIARIES


          With respect to the  unaudited consolidated financial  statements of
          Gerber Scientific, Inc.  at October 31, 1996  and for the three- and
          six-month periods  ended  October  31,  1996  and  1995,  KPMG  Peat
          Marwick LLP has  made a review (based  on procedures adopted  by the
          American Institute  of  Certified  Public  Accountants) and  not  an
          audit, as  set forth  in their  separate report  dated November  20,
          1996 appearing on page 8.  That report  does not express an  opinion
          on the interim unaudited  consolidated financial information.   KPMG
          Peat Marwick LLP has not carried  out any significant or  additional
          audit tests  beyond those which would  have been  necessary if their
          report had  not been included.   Accordingly, such  report is not  a
          "report" or "part of the Registration  Statement" within the meaning
          of  Sections  7  and 11  of  the  Securities  Act  of  1933 and  the
          liability provisions of Section 11 of such Act do not apply.


                                             -7-
<PAGE>9

                           INDEPENDENT ACCOUNTANTS' REPORT


          To the Board of Directors and Shareholders of
          Gerber Scientific, Inc.

          We  have made a review of the consolidated statements of earnings
          of  Gerber Scientific, Inc.  and subsidiaries for  the three- and
          six-month  periods  ended   October  31,  1996   and  1995,   the
          consolidated statement of  cash flows for  the six-month  periods
          ended  October 31, 1996  and 1995,  and the  consolidated balance
          sheet  as  of  October  31,  1996  in  accordance  with standards
          established  by  the  American  Institute   of  Certified  Public
          Accountants.   We have  previously  audited, in  accordance  with
          generally   accepted  auditing   standards,  and   expressed  our
          unqualified opinion  dated  May  23,  1996  on  the  consolidated
          financial  statements  for the  year  ended  April 30, 1996  (not
          presented herein).   The aforementioned financial  statements are
          the responsibility of the Company's management.

          A review of interim financial information consists principally of
          applying  analytical  review  procedures  to  financial data  and
          making  inquiries  of  persons   responsible  for  financial  and
          accounting  matters.  It is  substantially less in  scope than an
          examination  in  accordance   with  generally  accepted  auditing
          standards, the objective of which is the expression of an opinion
          regarding   the   financial   statements   taken  as   a   whole.
          Accordingly, we do not express such an opinion.

          Based  on  our  review,   we  are  not  aware  of   any  material
          modifications   that  should   be   made  to   the   accompanying
          consolidated statements of earnings for the three- and  six-month
          periods  ended  October  31,  1996  and  1995,  the  consolidated
          statement  of cash flows for the  six-month periods ended October
          31,  1996 and  1995,  or the  consolidated  balance sheet  as  of
          October  31, 1996  for them  to be  in conformity  with generally
          accepted  accounting  principles.    Also,  in  our  opinion  the
          information in the accompanying consolidated balance sheet as  of
          April  30, 1996 is fairly presented, in all material respects, in
          relation to the consolidated balance sheet from which it has been
          derived. 


                                        /s/ KPMG PEAT MARWICK LLP

          Hartford, Connecticut
          November 20, 1996 


                                             -8-
<PAGE>10

                       GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
                       MANAGEMENT'S DISCUSSION AND ANALYSIS OF

                    FINANCIAL CONDITION AND RESULTS OF OPERATIONS


          FINANCIAL CONDITION

          At  October 31,  1996 the  Company's ratio  of current  assets to
          current liabilities  was 3.0 to 1 compared with 2.8 to 1 at April
          30,  1996.  Net  working capital at  October 31,  1996 was $112.3
          million, an increase of  $10.6 million from the beginning  of the
          current  fiscal   year.    The  Company's   cash  and  short-term
          investments totaled  $7.3 million at October 31,  1996, which was
          lower than at  the end of the preceding fiscal  year but adequate
          for  the  Company's requirements.    In  addition, the  Company's
          portfolio  of longer-term  debt securities,  primarily tax-exempt
          municipal  bonds,  totaled $51.6  million  at  October 31,  1996,
          compared with $58.9 million at April 30, 1996.

          Operating activities  provided $.6 million  in cash for  the six-
          month  period ended October  31, 1996 compared  with $1.1 million
          used by operating activities for the same period last year.  Cash
          generated by  earnings and  depreciation and amortization  in the
          current  year  was  substantially  offset  by  higher  receivable
          balances.   The growth in  receivables was related  to the higher
          sales volume of business  and also to extended payment  terms for
          certain  sales  of  computer-to-plate  imaging  systems  for  the
          printing industry.

          The principal non-operating uses of cash for the six-month period
          ended  October 31,  1996 were additions  to property,  plant, and
          equipment  of $6.4 million and the payment of dividends on common
          stock  of $3.7  million.   The Company  anticipates that  capital
          expenditures  for the current fiscal year will be in the range of
          $12 to  $13 million and expects  to fund these with  cash on hand
          and cash from operations.

          The  Company's total debt at  October 31, 1996  was $7.4 million,
          down slightly  from April 30, 1996.   The ratio of  total debt to
          shareholders' equity  was 3.1 percent at October  31, 1996, which
          was unchanged from April  30, 1996.  The Company believes its low
          ratio of debt-to-equity is an  important indicator of its ability
          to borrow funds should needs arise.


                                             -9-
<PAGE>11
          RESULTS OF OPERATIONS

          Combined sales  and service revenue for the  three- and six-month
          periods ended October 31,  1996 increased by 5.3 percent  and 1.4
          percent, respectively, from the  same periods of last year.   The
          increases  came  from  both  higher  product  sales  and  service
          revenue.   Product sales rose  because of increased  shipments of
          computer-to-plate  imaging  systems  for  the  printing industry.
          Sales were  also  higher  in the  Company's  line  of  ophthalmic
          manufacturing systems  for the production of  eyeglass lenses and
          in  digital  imaging  and  routing  systems  for  the  signmaking
          industry.   These increases were partially offset by a decline in
          sales of automated fabric  cutting and spreading systems for  the
          apparel and related industries.

          The  consolidated  gross profit  margins  in  this year's  second
          quarter and first six  months were slightly lower than  the prior
          year  at 44.8 and 43.8  percent, respectively, compared with 45.4
          and 44.8  percent  for the  same periods  last year.   The  lower
          margins occurred in product sales  and resulted from lower  sales
          of  automated   fabric  cutting  systems  and  competitive  price
          discounting on these products, particularly in European markets.

          Selling,  general, and  administrative  expenses in  this  year's
          second quarter  and first six  months increased $2.4  million and
          $3.3  million, respectively, from the same periods last year.  On
          a percentage of sales basis, S,G & A increased 1 percentage point
          and  1.4 percentage  points  from the  prior  year levels  to  32
          percent and 32.6 percent of total revenue for the three- and six-
          month periods  ended  October  31,  1996,  respectively.    These
          increases were  the result of  advertising campaigns,  exhibition
          costs, and post  sales expenses associated with  the promotion of
          certain  new products, particularly for computer-to-plate imaging
          systems for the printing industry. 

          The Company continued to commit significant resources to research
          and the development of new products.  R&D expense of $7.4 million
          in this  year's second quarter and $14.2 million in the first six
          months  represented 7.8  and  7.9  percent  of revenue  in  these
          periods, respectively.   These percentages were  higher than  the
          prior   year  comparative   levels  of   6.7  and   6.8  percent,
          respectively.  This  higher level of  expenditure in the  current
          year reflected,  in  part,  the   development  efforts  aimed  at
          broadening  the  Company's  line of    computer-to-plate  imaging
          systems for the commercial printing industry.
                      
          Interest  expense for this  year's second  quarter and  first six
          months ended October 31, 1996 was slightly lower than in the same
          periods last year as a result of lower debt levels.  Other income
          in this year's  second quarter  and first six  months was  higher
          than  last year because of a gain  of $1 million ($.04 per share)
          from  life insurance benefits  received upon the death of Mr.  H.
          Joseph Gerber, the Company's former Chairman and President.  This
          gain was partially offset by lower interest income resulting from
          a smaller investment portfolio of tax-exempt municipal bonds.


                                         -10-
<PAGE>12

          The  provision rate for income  taxes for the  second quarter and
          six months ended October 31, 1996 was reduced as a  result of the
          tax-exempt  life insurance  benefits noted  above.   Without this
          item, the  tax provision  rate would  have been  approximately 30
          percent  for  this year's  second quarter  and first  six months,
          compared  with approximately 29 percent in  the same periods last
          year.  The effective income  tax rate continued to be lower  than
          the 35 percent  statutory U.S. Federal tax rate primarily because
          of tax-exempt interest income, the  tax benefits of the Company's
          foreign  sales corporation, and,  in the  current year,  the tax-
          exempt life insurance benefits.

          As  a result of the above,  net earnings decreased in this year's
          second  quarter to  $5.1  million or  $.22  per share  from  $5.5
          million or $.23 per share in last year's second quarter.  For the
          first  six  months, net  earnings  this  year  decreased to  $6.7
          million or $.29 per share compared with $10.0 million or $.42 per
          share in the prior year.

          FORWARD LOOKING STATEMENTS

          This report includes forward-looking statements that describe the
          Company's business  prospects.    Readers  should  keep  in  mind
          factors that  could have an  adverse impact  on those  prospects.
          These include  political, economic, or other  conditions, such as
          recessionary  or  expansive  trends,  inflation  rates,  currency
          exchange  rates,  taxes,  regulations,  and  laws  affecting  the
          business, as well as product competition, pricing,  the degree of
          acceptance of new products to the marketplace, and the difficulty
          of forecasting sales at various times in various markets.


                                            -11-
<PAGE>13

                             PART II - OTHER INFORMATION

          Item 4.  Submission of Matters to a Vote of Security Holders

          At the  Registrant's  Annual  Meeting  of  Shareholders  held  on
          September  27,  1996,  the  shareholders  voted  on  one   matter
          regarding the election of Directors.  The shareholders elected A.
          Robert Towbin and David J. Logan as Directors to serve  for terms
          expiring at the 1999 annual meeting.   The terms of office of the
          other Directors,  George M.  Gentile,  Stanley Simon,  Edward  E.
          Hood,  Jr., W. Jerome Vereen, and David J. Gerber continued after
          the meeting.

          Votes cast in the election of Directors were as follows:

                                               Votes          Votes
                                                For          Against
                                           ------------     ---------
             A. Robert Towbin              21,394,656       193,623
             David J. Logan                21,404,118       184,161

          Item 5.  Other Information

          On August 2, 1996,  the Company issued a press  release reporting
          the appointment  of Mr.  George M. Gentile  as President,  acting
          Chief  Executive  Officer, and  Chief  Operating  Officer of  the
          Company.  Mr. Gentile's appointment  was on the recommendation of
          Mr. H.  Joseph  Gerber, the  then  Chairman and  Chief  Executive
          Officer  of the Company, and  was due to  Mr. Gerber's continuing
          illness.    Mr.  Gentile  had  been  the  Company's  Senior  Vice
          President, Finance  and Chief Financial  Officer, and has  been a
          Director since 1989.

          On August 8, 1996,  the Company issued a press  release reporting
          the death of Mr. H. Joseph Gerber.

          On  August 19, 1996,  the Company's Board  of Directors appointed
          Mr.  Gentile as  Chairman  and  Chief  Executive Officer  of  the
          Company.     The  Board  also  appointed  Mr.  Gary  K.  Bennett,
          previously  Vice  President,  Treasurer  and  Controller  of  the
          Company, as Senior  Vice President, Finance  and Chief  Financial
          Officer.

          Item 6.  Exhibits and Reports on Form 8-K

          (a)  Exhibits

                 (11)  Statement   regarding   computation  of   per  share
                        earnings.

                 (15)  Letter   regarding   unaudited   interim   financial
                       information.

                 (27)  Financial data Schedule.

          (b)    Reports on Form 8-K

                 No Form  8-K was filed  during the quarter  for which this
                 report is filed.


                                            -12-
<PAGE>14

                                       SIGNATURE



            Pursuant  to the requirements of the Securities Exchange Act of
            1934, the Registrant has duly  caused this report to  be signed
            on its behalf by the undersigned, thereunto duly authorized.




                                            GERBER SCIENTIFIC, INC.
                                            -----------------------
                                                  (Registrant)




            Date:  November 22, 1996        By:/s/  Gary K. Bennett        
                  -------------------       ------------------------------
                                            Senior Vice President, Finance
                                            and Principal Accounting Officer






                                          -13-
<PAGE>15

                                     EXHIBIT INDEX
                                     -------------


            Exhibit Index
               Number                  Exhibit                        Page
            -------------              -------                        ----

                 11            Statement Regarding Computation         17
                               of Per Share Earnings.*   

                 15            Letter Regarding Unaudited Interim      18 
                               Financial Information.*

                 27            Financial Data Schedule                 19 



            *Filed herewith.


<PAGE>16

<TABLE>
<CAPTION>                                                                 EXHIBIT NO. 11


                              GERBER SCIENTIFIC, INC. AND SUBSIDIARIES

                                 COMPUTATION OF PER SHARE EARNINGS


                                             Three Months                 Six Months
                                                Ended                        Ended
                                              October 31                  October 31           
                                     ---------------------------   ---------------------------
                                         1996           1995           1996           1995    
                                     ------------   ------------   ------------   ------------
   <S>                               <C>            <C>            <C>            <C>  

   Net earnings                      $  5,135,000   $  5,533,000   $  6,738,000   $ 10,026,000
                                     ============   ============   ============   ============ 



   Weighted average shares of
     common stock outstanding
     during the period                 23,231,530     23,617,533     23,220,984     23,692,944


   Common stock equivalents:

     Common stock attributable
     to stock options (treasury
     stock method)                         95,580        294,262        129,042        261,296
                                     ------------   ------------   ------------   ------------


   Average common shares
     outstanding                       23,327,110     23,911,795     23,350,026     23,954,240
                                     ============   ============   ============   ============


     Net earnings per common share   $        .22   $        .23   $        .29   $        .42
                                     ============   ============   ============   ============
</TABLE>

<PAGE>17

                                                                  EXHIBIT NO. 15



            To the Board of Directors and Shareholders of
          Gerber Scientific, Inc.


                     
                        Re:  Registration Statements on Form S-8, 
                             File No. 2-93695 and No. 33-58668

                             Registration Statement on Form S-3,
                             File No. 33-58670



          With  respect   to  the   subject  Registration  Statements,   we
          acknowledge  our awareness of the use therein of our report dated
          November  20, 1996  related to  our review  of  interim financial
          information.

          Pursuant to Rule  436(c) under the  Securities Act, such  reports
          are not considered a part of a Registration Statement prepared or
          certified by an accountant  or a report prepared or  certified by
          an accountant within the meaning of Sections 7 and 11 of the Act.


                                          Very truly yours,

                                          /s/ KPMG PEAT MARWICK LLP


          Hartford, Connecticut
          November 20, 1996
<PAGE>18